DENTSPLY SIRONA Inc. (XRAY) Interest Coverage Ratio: 2.86x
The interest coverage ratio for DENTSPLY SIRONA Inc. (XRAY) is 2.86x as of Sunday, June 14, 2026.
XRAY Interest Coverage Ratio Metrics
INTEREST COVERAGE RATIO
2.86x
XRAY Competitors' Interest Coverage Ratio
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| DENTSPLY SIRONA Inc. (XRAY) | $2.02B | 2.86x | N/A | N/A | N/A |
| 23andMe Holding Co. (ME) | $15.31M | N/A | N/A | N/A | N/A |
| Hims & Hers Health, Inc. (HIMS) | $5.98B | N/A | N/A | N/A | N/A |
| Bio-Rad Laboratories, Inc. (BIO) | $7.73B | 5.52x | 5.51x | 7.63x | 62.06x |
| Tempus AI, Inc. (TEM) | $8.35B | -3.40x | N/A | N/A | N/A |
| Charles River Laboratories International, Inc. (CRL) | $9.03B | 4.74x | 3.27x | 5.51x | 5.84x |
| Walgreens Boots Alliance, Inc. (WBA) | $10.37B | -29.20x | 3.03x | 3.75x | 5.52x |
| Baxter International Inc. (BAX) | $10.77B | -1.06x | 0.71x | 2.65x | 6.89x |
| Align Technology, Inc. (ALGN) | $12.52B | N/A | 67.41x | 66.08x | 407.22x |
| The Cooper Companies, Inc. (COO) | $13.24B | 6.83x | 6.50x | 6.73x | 9.55x |
Financial Health Indicators
Interest Coverage
2.9x
Debt/Equity
1.84
Current Ratio
1.51
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
- < 1.5x: EBIT is less than 1.5 times interest expense
- 1.5x - 3x: EBIT is between 1.5 and 3 times interest expense
- 3x - 5x: EBIT is between 3 and 5 times interest expense
- > 5x: EBIT is more than 5 times interest expense
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
DENTSPLY SIRONA Inc. Interest Coverage Ratio Formula & Definition
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
DENTSPLY SIRONA Inc. Interest Coverage Ratio FAQ
- What is the interest coverage ratio for DENTSPLY SIRONA Inc. (XRAY)?
- The interest coverage ratio for XRAY stock is 2.86x.
About DENTSPLY SIRONA Inc.
DENTSPLY SIRONA Inc. is a global enterprise specializing in the production and distribution of a diverse range of dental products and advanced technologies, primarily serving the professional dental sector worldwide. Its business operations are structured into two principal divisions: Technologies & Equipment, and Consumables. The Technologies & Equipment division offers an array of sophisticated dental apparatus, including patient treatment units, advanced imaging systems, and powered dental handpieces, designed for both general practitioners and specialized dentists. This segment also encompasses cutting-edge CAD/CAM technologies, facilitating digital dental processes like restorations within dental practices. Furthermore, it provides clear aligner systems, such as the professional-grade SureSmile and options directly for consumers, alongside high-frequency vibration therapy devices and dental implants. Complementing its dental offerings, this division also supplies urology catheters and various other healthcare-related consumables. Conversely, the Consumables division focuses on a wide spectrum of expendable and replenishable items. This includes endodontic supplies vital for root canal treatments, such as specialized drills, files, sealers, and irrigation needles. It also encompasses restorative materials like artificial teeth, dental ceramics, digitally fabricated dentures, precious metal alloys for dentistry, and porcelain for crowns and bridges. Additionally, this segment offers compact dental devices like intraoral curing light systems, diagnostic tools, and ultrasonic scaling and polishing units, alongside a variety of everyday dental care products such as anesthetics, prophylactic pastes, sealants, impression compounds, teeth whitening agents, and topical fluoride applications. Established in 1877, DENTSPLY SIRONA Inc. maintains its corporate headquarters in Charlotte, North Carolina.
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- CEO
- Daniel T. Scavilla